The Latest Cardiac and Vascular News
WILMINGTON, Mass.–(BUSINESS WIRE)–Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that aim to improve clinical outcomes and quality of life, announced a major milestone today in the development of its MicroStent technology, a vascular stent specifically designed to reduce below-the-knee amputations caused by critical limb ischemia […]
KIBBUTZ SHEFAYIM, Israel–(BUSINESS WIRE)–Zebra Medical Vision (https://www.zebra-med.com/), the leading machine and deep learning startup, is announcing today it has raised $30M in C round funding, bringing the total investment in the company to $50M. In addition, the company is unveiling its Textray chest x-ray research (https://arxiv.org/abs/1806.02121) today, the most comprehensive AI research conducted on […]
CONSHOHOCKEN, Pa., June 05, 2018 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases, today announced that it has commenced an underwritten public offering of $200 million of its […]
LAVAL, Québec, June 06, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST) (the “Company” or “Acasti Pharma”), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that the Company is scheduled to […]
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, today announces the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions. Heilmann will lead […]
HONG KONG, June 06, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, is pleased to announce that its wholly owned subsidiary, Novoheart Limited, has been awarded a non-dilutional government grant of C$400,000 from the Innovation and Technology Commission (ITC) of Hong Kong. The […]
REDWOOD CITY, Calif., June 06, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that its Bioflux device has won the prestigious MedTech Breakthrough Award 2018 for Best Remote Patient Monitoring Solution. MedTech Breakthrough, an independent organization that recognizes […]
VANCOUVER, June 6, 2018 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the Brinavess®study, titled “Vernakalant in hospital emergency practice: safety and effectiveness,” published by José Carbajosa Dalmau (Alicante, Spain), was awarded first prize for the best work published during […]
TOKYO and BASKING RIDGE, N.J., June 6, 2018 /PRNewswire/ — Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. announced today that more than 97 percent of eligible claimants have opted into the product liability litigation settlement program announced on August 1, 2017 for cases brought against various Daiichi Sankyo and Forest entities. These cases are related to […]
VANCOUVER, June 4, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on June 4, 2018 in Vancouver, B.C. (the “Meeting”). At the Meeting, the shareholders of the Company (the “Shareholders”) re-elected […]
